Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7638299 Biosynthetic polypeptides utilizing non-naturally encoded amino acids

Patent 7638299 was granted and assigned to Ambrx on December, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ambrx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76382990

Patent Inventor Names

William M. Keefe0

Anna-Maria Hays0

Bruce E. Kimmel0

David C. Litzinger0

Ho Sung Cho0

Roberto Mariani0

Thomas O. Daniel0

Troy E. Wilson0

Date of Patent

December 29, 2009

Patent Application Number

111876870

Date Filed

July 21, 2005

Patent Citations Received

‌

US Patent 11834521 Ultra-pure agonists of guanylate cyclase C, method of making and using same

‌

US Patent 11786578 Modified relaxin polypeptides and their uses

Patent Primary Examiner

‌

Andrew Wang

Patent abstract

Modified biosynthetic polypeptide molecules, methods for manufacturing, and uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7638299 Biosynthetic polypeptides utilizing non-naturally encoded amino acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API